6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
4F25
23-25
Nov
2026
CPHI India 2026
IICC, Yashobhoomi, Dwarka, Delhi
2I06

Sekhmet Pharmaventures Pvt. Ltd.

About Sekhmet Pharmaventures Pvt. Ltd.

Gamot API is the holding company of Sekhmet Pharmaventures Pvt. Ltd. Asian private equity major PAG has formed an investment platform called Gamot API Pte. Ltd. based in Singapore, along with Indian private equity firms, CX Partners and Samara Capital, to buy stakes in fast-growing Indian pharma companies. The Indian subsidiary of Gamot API is known as Sekhmet Pharmaventures Pvt. Ltd. Sekhmet Pharmaventures has acquired major stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020. Subsequently, Sekhmet Pharmaventures acquired major stake in Optimus Drugs Group of Companies in May 2022. The Company plans to invest in multiple manufacturing facilities dedicated to Active Pharmaceutical...

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • CPHI India 2026

    IICC, Yashobhoomi, Dwarka, Delhi
    23 Nov 2026 - 25 Nov 2026
  • Country/Region:
    India
  • On CPHI since:
    2015
Company types
CMO/CDMO
Manufacturer/Innovator
Contact info
  • 2nd Floor, Sy No. 37/A & 37/P, Plot No.6P, , Signature Towers, Kothaguda, Kondapur, 500 084, Hyderabad, Telangana, India

Products from Sekhmet Pharmaventures Pvt. Ltd. (2)

  • APIs

    Product APIs

    API are offered from US FDA/EU GMP/ COFEPRIS MEXICO/KFDA/WHO GENIVA approved facility. 
  • Formulations

    Product Formulations

    Formulations - Pellets/FDF dossiers etc.